The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
Cognitive neuroscientist Eleanor Maguire, PhD, whose studies of London taxi drivers' brains helped transform memory research, ...
A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...
Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer ...
Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.